Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Practical points for applying herpes zoster vaccine recommendations

Brogie, Jackie D.; Rumph, Joshua H.; Chaplin, Michelle D. PharmD, BCACP, CDE; Drake, Nicole MSM, PA-C; Hodge, Bryan K. DO; Owens, Ryan E. PharmD, BCPS

doi: 10.1097/01.NPR.0000574676.64980.7e
Feature: IMMUNIZATIONS
Buy

Abstract: The recombinant zoster vaccine (Shingrix) was approved to help combat the incidence of shingles in patients age 50 years and older and the CDC now recommends it over the zoster vaccine live (Zostavax). This article highlights practical considerations to help clinicians appropriately apply the most recent vaccine recommendations to their patients.

The recombinant zoster vaccine (Shingrix) was approved to help combat the incidence of shingles in patients age 50 years and older and the CDC now recommends it over the zoster vaccine live (Zostavax). This article highlights practical considerations to help clinicians appropriately apply the most recent vaccine recommendations to their patients.

Jackie D. Brogie is a pharmacy student at Wingate University School of Pharmacy, Hendersonville, N.C.

Joshua H. Rumph is a pharmacy student at Wingate University School of Pharmacy, Hendersonville, N.C.

Michelle D. Chaplin is an associate professor at Wingate University School of Pharmacy, Hendersonville, N.C.

Nicole A. Drake is an assistant professor at Wingate University Physician Assistant Program, Hendersonville, N.C.

Bryan K. Hodge is a family medicine physician and director of rural health initiatives at Mountain Area Health Education Center, Hendersonville, N.C.

Ryan E. Owens is an assistant professor at Wingate University School of Pharmacy; Hendersonville, N.C.

The authors have disclosed no financial relationships related to this article.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.